Amedisys, Inc. (AMED)
| Market Cap | 3.10B |
| Revenue (ttm) | 2.23B |
| Net Income (ttm) | 2.65M |
| Shares Out | 32.63M |
| EPS (ttm) | 0.07 |
| PE Ratio | 1,358.00 |
| Forward PE | 21.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 177,891 |
| Open | 95.10 |
| Previous Close | 95.04 |
| Day's Range | 94.24 - 95.17 |
| 52-Week Range | 69.36 - 106.02 |
| Beta | 0.92 |
| Analysts | Hold |
| Price Target | 102.91 (+8.26%) |
| Earnings Date | Feb 14, 2024 |
About AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social ... [Read more]
Financial Performance
In 2022, Amedisys's revenue was $2.22 billion, an increase of 0.41% compared to the previous year's $2.21 billion. Earnings were $118.61 million, a decrease of -43.27%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $102.91, which is an increase of 8.26% from the latest price.
News
Amedisys Reports Third Quarter 2023 Financial Results
BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.
Amedisys Celebrates National Quality Week
Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care
Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline
BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suici...
Amedisys Reports Second Quarter 2023 Financial Results
BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Amedisys, Inc. by Option Care Health, Inc.
NEW YORK , June 29, 2023 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Amedisys, Inc. (" Amedisys" or the "Company") (NAS...
UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems
In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, as had been reported here, Amedisys, the home health an...
UnitedHealth Buys Amedisys for $3.3 Billion
UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys.
Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger
The unsolicited offer from UnitedHealth outbid a $2.8 billion deal.
Amedisys Agrees to $3.3 Billion UnitedHealth Merger
Home health company Amedisys has agreed to a $3.3 billion merger with UnitedHealth Group. The deal calls for the acquisition of Amedisys' outstanding common stock in an all-cash transaction for $101 p...
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQ: AMED) to Optum for $101.00 per share is fair to Amedisys sharehol...
UnitedHealth Agrees All-Cash Deal to Buy Amedisys
The move for the healthcare-service provider is worth $101 a share.
Amedisys agrees to UnitedHealth buyout offer, scraps Option Care deal
Amedisys Inc on Monday agreed to acquired by UnitedHealth Group for $101 per share in cash, and terminated an all-stock deal to be bought by Option Care Health Inc.
Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health
Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early...
Amedisys and Optum to Combine, Advancing Value-Based Care for Patients
BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agr...
Optum Bid for Amedisys Shows Ongoing Reinvention of the Private Healthcare Ecosystem
The growing yet fragmented home health space is moving toward a more consolidated and centralized footing one deal at a time as major players continue snapping up smaller ones, reinventing home health...
Optum Offers To Combine With Amedisys, Advancing Value-Based Care for Patients
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Optum offers to combine with Amedisys, a leading provider of home health, hospice and high-acuity care.
Amedisys received unsolicited buyout bid from Optum that could be ‘superior' to deal with Option Care Health
Amedisys Inc. AMED, +3.64% disclosed Monday that it had received an unsolicited cash buyout bid for $100 a share from Optum, which the at-home healthcare services company believes could be considered ...
Amedisys gets over $3 billion unsolicited offer from UnitedHealth's Optum
Amedisys Inc said on Monday it had received an unsolicited proposal from UnitedHealth Group's health services company Optum to acquire all of its outstanding shares in an all-cash transaction worth $3...
Amedisys Announces Receipt of Unsolicited Proposal From Optum
Amedisys Board Determines Optum Proposal Could Reasonably be Expected to Result in a Superior Proposal
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (...
ALERT: Rowley Law PLLC is Investigating Proposed Merger of Amedisys, Inc.
NEW YORK , May 4, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Amedisys, Inc. (NASDAQ: AMED) and its board of directors concerning the proposed merger o...
Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health
MILWAUKEE , May 3, 2023 /PRNewswire/ -- Ademi LLP is investigating Amedisys (NASDAQ: AMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Option Care Healt...
AMEDISYS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND UPDATES 2023 GUIDANCE
BATON ROUGE, La. , May 3, 2023 /PRNewswire/ -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2023.
Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Acro...
HouseWorks Announces Acquisition of Amedisys' Personal Care Division
HouseWorks and Amedisys form Care Coordination Partnership to Enhance Amedisys Personal Care Network HouseWorks and Amedisys form Care Coordination Partnership to Enhance Amedisys Personal Care Networ...